SKIN
SkinHealth Systems Inc.
NasdaqCMUSDEQUITY
Consumer Defensive
DELAYED
Strong sell
-67/100
Last price
0.59
▼ 0.01 (2.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.63
Prev close
0.60
Day high
0.63
Day low
0.58
Volume
418.55K
Market cap
$76.26M
P/E (TTM)
—
52W range
0.55 – 1.76
Day trading desk
Gap from prior close
+5.00%
Prior close 0.60
VWAP
0.59
-0.08% from price
Relative volume
1.29×
Normal
Session range
9.03%
0.58 – 0.63
Position in range
16%
Near session low
ATR (14D)
0.04
7.65% of price
Prior day high
0.64
PDH
Prior day low
0.57
PDL
Bid / ask spread
—
Quote not published
Session volume
831.88K
Avg 646.79K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.64%
-7.6%
1M
-14.45%
-15.6%
3M
-44.19%
-48.7%
6M
-33.18%
-51.4%
YTD
-57.84%
-72.1%
1Y
-65.12%
-81.5%
3Y
-90.27%
-172.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SKIN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
16.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 20, 26 | MONAHAN MICHAEL P Chief Financial Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | MENEZES RONALD Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | LEWIS SHERI Chief Operating Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | MALHA PEDRO BRUNO FERREIRA Chief Executive Officer |
STOCK | 2.65M | $0 | Direct |
| Nov 13, 25 | SCHAISON PHILIPPE Director |
STOCK | 57.69K | $0 | Direct |
| Oct 9, 25 | MALHA PEDRO BRUNO FERREIRA Chief Executive Officer |
STOCK | 2.19M | $3.42M | Direct |
| Jun 16, 25 | KERRICK MICHELLE C. Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | GRUBER DESIREE Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | SCHILLINGER DOUG K. Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | MILLER BRIAN CHRISTOPHER Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | FANNING STEPHEN J Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | SAUNDERS BRENT L. Chairman of the Board |
STOCK | 73.05K | $0 | Direct |
| Mar 17, 25 | MONAHAN MICHAEL P Chief Financial Officer |
STOCK | 639.20K | $843.75K | Direct |
| Mar 17, 25 | BECK MARLA MALCOLM Chief Executive Officer |
STOCK | 1.83M | $2.42M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BECK MARLA MALCOLM |
Chief Executive Officer | 2.85M | Stock Award(Grant) |
FANNING STEPHEN J |
Director | 527.28K | Stock Award(Grant) |
GRUBER DESIREE |
Director | 192.56K | Stock Award(Grant) |
LEWIS SHERI |
Chief Operating Officer | 1.61M | Stock Award(Grant) |
MALHA PEDRO BRUNO FERREIRA |
Chief Executive Officer | 4.85M | Stock Award(Grant) |
MENEZES RONALD |
Officer | 1.76M | Stock Award(Grant) |
MILLER BRIAN CHRISTOPHER |
Director | 243.03K | Stock Award(Grant) |
MONAHAN MICHAEL P |
Chief Financial Officer | 2.01M | Stock Award(Grant) |
SAUNDERS BRENT L. |
Chairman of the Board | 8.80M | Stock Award(Grant) |
SCHILLINGER DOUG K. |
Director | 216.03K | Stock Award(Grant) |
Fundamentals
Market cap$76.26M
Enterprise value$239.23M
Revenue (TTM)$290.05M
Gross profit$192.45M
EBITDA$20.08M
Net income$-28.43M
EPS (TTM)$-0.22
Free cash flow$27.48M
Total cash$204.07M
Total debt$367.04M
Book value / share$0.43
Shares outstanding130.14M
Float55.73M
Short % of float15.21%
Dividend yield0.00%
Beta (5Y)1.05
Valuation & profitability ratios
Trailing P/E—
Forward P/E3.08
PEG ratio0.93
Price / sales—
Price / book1.37
EV / revenue0.83
EV / EBITDA11.91
Gross margin66.35%
Operating margin4.95%
Profit margin-9.80%
Return on equity-43.89%
Return on assets-0.54%
Debt / equity660.53
Current ratio1.76
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $300.79M | $334.29M | $397.99M | $365.88M | -10.0% |
| Operating revenue | $300.79M | $334.29M | $397.99M | $365.88M | -10.0% |
| Cost of revenue | $104.43M | $152.00M | $242.88M | $117.10M | -31.3% |
| Gross profit | $196.36M | $182.30M | $155.11M | $248.78M | +7.7% |
| Research & development | $5.63M | $6.30M | $10.10M | $8.44M | -10.6% |
| Selling, general & admin | $211.54M | $243.77M | $275.93M | $266.18M | -13.2% |
| Total operating expense | $217.17M | $250.07M | $286.03M | $274.62M | -13.2% |
| Operating income | -$20.80M | -$67.77M | -$130.92M | -$25.84M | +69.3% |
| Net interest income | -$10.37M | $6.23M | $9.52M | -$4.22M | -266.4% |
| Pre-tax income | -$5.94M | -$29.55M | -$101.89M | $45.34M | +79.9% |
| Tax provision | $3.58M | -$452.00K | -$1.77M | $1.11M | +892.3% |
| Net income | -$9.52M | -$29.10M | -$100.12M | $44.22M | +67.3% |
| Net income to common | -$9.52M | -$29.10M | -$100.12M | $44.22M | +67.3% |
| Basic EPS | -0.08 | -0.23 | -0.76 | 0.30 | +65.2% |
| Diluted EPS | -0.16 | -0.23 | -0.76 | 0.23 | +30.4% |
| EBIT | $13.39M | -$19.14M | -$88.24M | $58.73M | +170.0% |
| EBITDA | $38.74M | $14.54M | -$53.56M | $81.60M | +166.4% |
| Basic shares | 126.38M | 123.83M | 131.68M | 147.55M | +2.1% |
| Diluted shares | 135.80M | 123.83M | 131.68M | 148.51M | +9.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $232.67M | $370.06M | $523.02M | $568.20M | -37.1% |
| Cash & short-term investments | $232.67M | $370.06M | $523.02M | $568.20M | -37.1% |
| Accounts receivable | $21.74M | $27.64M | $54.70M | $76.49M | -21.4% |
| Inventory | $48.01M | $69.11M | $91.32M | $109.66M | -30.5% |
| Total current assets | $309.52M | $477.12M | $698.25M | $783.27M | -35.1% |
| Property, plant & equipment | $14.11M | $19.57M | $26.35M | $33.82M | -27.9% |
| Goodwill & intangibles | $162.38M | $171.01M | $187.94M | $170.98M | -5.0% |
| Total assets | $499.80M | $685.68M | $929.11M | $1.00B | -27.1% |
| Total current liabilities | $186.28M | $68.15M | $115.01M | $71.71M | +173.3% |
| Current debt | $123.96M | — | — | — | — |
| Long-term debt | $240.43M | $552.20M | $738.37M | $734.14M | -56.5% |
| Total debt | $378.76M | $568.16M | $752.29M | $751.79M | -33.3% |
| Total liabilities | $438.75M | $633.88M | $869.72M | $836.03M | -30.8% |
| Retained earnings | -$517.48M | -$507.96M | -$478.87M | -$378.75M | -1.9% |
| Shareholder equity | $61.06M | $51.80M | $59.39M | $167.05M | +17.9% |
| Working capital | $123.24M | $408.97M | $583.24M | $711.56M | -69.9% |
| Net tangible assets | -$101.33M | -$119.21M | -$128.55M | -$3.93M | +15.0% |
| Shares issued | 127.52M | 124.92M | 122.90M | 132.21M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$9.52M | -$29.10M | -$100.12M | $44.22M | +67.3% |
| Depreciation & amortisation | $25.35M | $33.68M | $34.67M | $22.87M | -24.7% |
| Stock-based compensation | $14.82M | $26.70M | $22.54M | $28.50M | -44.5% |
| Change in working capital | $10.37M | -$27.39M | $23.36M | -$145.27M | +137.9% |
| Operating cash flow | $37.48M | $16.13M | $21.75M | -$106.60M | +132.3% |
| Capital expenditure | -$5.16M | -$6.79M | -$13.05M | -$17.39M | +24.0% |
| Investing cash flow | -$5.16M | -$6.79M | -$31.51M | -$18.87M | +24.0% |
| Share buybacks | $0 | $0 | -$32.40M | -$160.00M | — |
| Financing cash flow | -$174.93M | -$158.34M | -$37.45M | -$205.24M | -10.5% |
| Free cash flow | $32.32M | $9.34M | $8.70M | -$123.99M | +246.1% |
| End cash position | $232.67M | $370.06M | $523.02M | $568.20M | -37.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $72.11M | $64.91M | $82.37M | $70.66M | $78.19M | +11.1% |
| Operating revenue | $72.11M | $64.91M | $82.37M | $70.66M | $78.19M | +11.1% |
| Cost of revenue | $22.77M | $20.47M | $29.33M | $25.02M | $29.07M | +11.3% |
| Gross profit | $49.34M | $44.44M | $53.04M | $45.63M | $49.11M | +11.0% |
| Research & development | $1.41M | $1.10M | $1.68M | $1.70M | $1.25M | +27.7% |
| Selling, general & admin | $44.36M | $45.14M | $51.20M | $50.18M | $50.56M | -1.7% |
| Total operating expense | $45.77M | $46.24M | $52.88M | $51.88M | $51.81M | -1.0% |
| Operating income | $3.57M | -$1.80M | $162.00K | -$6.24M | -$2.70M | +298.3% |
| Net interest income | -$5.00M | -$4.86M | -$4.86M | -$5.05M | -$986.00K | -3.0% |
| Pre-tax income | -$1.46M | -$6.81M | -$4.81M | -$10.64M | $18.72M | +78.6% |
| Tax provision | $1.21M | -$184.00K | $3.30M | $386.00K | -$993.00K | +756.5% |
| Net income | -$2.67M | -$6.63M | -$8.10M | -$11.03M | $19.71M | +59.7% |
| Net income to common | -$2.67M | -$6.63M | -$8.10M | -$11.03M | $19.71M | +59.7% |
| Basic EPS | -0.02 | -0.05 | -0.06 | -0.09 | 0.16 | +60.0% |
| Diluted EPS | -0.02 | -0.05 | -0.06 | -0.09 | 0.03 | +60.0% |
| EBIT | $4.83M | -$468.00K | $1.56M | -$4.33M | $22.86M | +1,132.9% |
| EBITDA | $10.11M | $4.87M | $6.92M | $4.10M | $28.26M | +107.6% |
| Basic shares | 129.60M | 127.79M | 127.44M | 126.89M | 126.07M | +1.4% |
| Diluted shares | 129.60M | 131.40M | 127.44M | 126.89M | 140.29M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $206.07M | $204.36M | $232.67M | $219.40M | $212.00M | +0.8% |
| Cash & short-term investments | $206.07M | $204.36M | $232.67M | $219.40M | $212.00M | +0.8% |
| Accounts receivable | $17.64M | $18.61M | $21.74M | $22.21M | $25.05M | -5.2% |
| Inventory | $46.84M | $47.69M | $48.01M | $56.15M | $59.19M | -1.8% |
| Total current assets | $295.24M | $277.69M | $309.52M | $308.37M | $306.11M | +6.3% |
| Property, plant & equipment | $21.48M | $22.63M | $14.11M | $16.66M | $15.24M | -5.1% |
| Goodwill & intangibles | $156.57M | $159.04M | $162.38M | $164.48M | $169.76M | -1.6% |
| Total assets | $486.57M | $473.23M | $499.80M | $503.64M | $507.56M | +2.8% |
| Total current liabilities | $168.20M | $155.20M | $186.28M | $61.90M | $59.44M | +8.4% |
| Current debt | $103.09M | $102.94M | $123.96M | — | — | +0.1% |
| Long-term debt | $242.12M | $241.28M | $240.43M | $363.39M | $363.10M | +0.3% |
| Total debt | $367.04M | $367.13M | $378.76M | $378.98M | $376.73M | -0.0% |
| Total liabilities | $431.00M | $417.99M | $438.75M | $437.98M | $433.56M | +3.1% |
| Retained earnings | -$526.78M | -$524.11M | -$517.48M | -$509.38M | -$498.35M | -0.5% |
| Shareholder equity | $55.57M | $55.24M | $61.06M | $65.66M | $74.00M | +0.6% |
| Working capital | $127.04M | $122.49M | $123.24M | $246.46M | $246.67M | +3.7% |
| Net tangible assets | -$101.00M | -$103.80M | -$101.33M | -$98.82M | -$95.76M | +2.7% |
| Shares issued | 130.10M | 129.14M | 127.52M | 127.30M | 126.76M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.67M | -$6.63M | -$8.10M | -$11.03M | $19.71M | +59.7% |
| Depreciation & amortisation | $5.27M | $5.34M | $5.35M | $8.43M | $5.40M | -1.2% |
| Stock-based compensation | $2.90M | $2.08M | $3.58M | $2.46M | $5.31M | +39.2% |
| Change in working capital | -$5.36M | -$9.14M | $7.88M | $4.10M | -$4.54M | +41.4% |
| Operating cash flow | $2.67M | -$5.55M | $15.20M | $9.65M | $9.65M | +148.1% |
| Capital expenditure | -$1.21M | -$1.65M | -$1.38M | -$1.08M | -$1.55M | +26.9% |
| Investing cash flow | -$1.21M | -$1.65M | -$1.38M | -$1.08M | -$1.55M | +26.9% |
| Financing cash flow | -$224.00K | -$20.91M | -$512.00K | -$803.00K | -$173.36M | +98.9% |
| Free cash flow | $1.47M | -$7.20M | $13.81M | $8.56M | $8.09M | +120.4% |
| End cash position | $206.07M | $204.36M | $232.67M | $219.40M | $212.00M | +0.8% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
0.50
-14.7% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
1
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
0.50
0 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | — | 0.08 | — |
| Mar 2026 | — | 0.03 | — |
| Dec 2025 | -0.05 | -0.06 | -10.1% |
| Sep 2025 | -0.05 | 0.03 | +156.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.00 | 1 | $67.93M | -3.9% |
| Next quarter | -0.02 | 8 | $80.26M | -2.6% |
| Current year | 0.13 | 1 | $285.10M | -5.2% |
| Next year | 0.19 | 1 | $299.01M | +4.9% |
Analyst targets & ownership
Mean target$0.99
High target$1.50
Low target$0.70
Implied upside69.23%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 1
Hold6
Sell / Strong sell0 / 2
Held by insiders13.03%
Held by institutions77.17%
Institutions holding120
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.63
-7.70% from price
SMA 20
0.66
-11.09% from price
SMA 50
0.67
-12.24% from price
SMA 100
0.70
-16.28% from price
SMA 200
0.92
-36.26% from price
EMA 12
0.63
-7.57% from price
EMA 26
0.65
-10.53% from price
EMA 50
0.68
-13.49% from price
RSI (14)
31.4
Neutral
MACD (12,26,9)
-0.02
Hist -0.01
ATR (14)
0.04
7.65% of price
Realised vol 30D
45.7%
Annualised
Bollinger upper
0.72
20, 2σ
Bollinger lower
0.60
20, 2σ
50 / 200 cross
Death
0.67 vs 0.92
Trend bias
Below 200
-36.26%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.15
More volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
45.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-65.9%
Peak to trough
Max drawdown 5Y
-98.0%
Peak to trough
ATR 14
0.04
7.65% of price
Beta (reported)
1.05
5Y monthly, from filing
Short interest
Shares short
7.18M
Prior 7.07M
Change vs prior
+1.6%
Shorts adding
% of float
15.21%
Elevated
% of shares out
5.52%
Against total outstanding
Days to cover
19.6
Crowded exit
Float
55.73M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| May 20, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| May 1, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Mar 16, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Mar 13, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Jan 21, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Sep 22, 25 | TD Cowen | MAINTAINED | Hold | Hold |
| Sep 19, 25 | Roth Capital | INITIATED | — | Buy |
| May 5, 25 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Mar 13, 25 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Nov 13, 24 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Aug 12, 24 | Canaccord Genuity | MAINTAINED | Hold | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Corporate Changes & Voting Matters
8-K · 2026-09-28
Corporate Changes & Voting Matters
8-K · 2026-09-10
Corporate Changes & Voting Matters
8-K · 2026-08-14
Proxy Statements
DEF 14A · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-08-06
Proxy Statements
PRE 14A · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-06-22
Headlines
Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin
GlobeNewswire · 18h ago
SkinHealth Systems Launches Microneedling Device in Europe
MT Newswires · 6d ago
SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
GlobeNewswire · 6d ago
SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit
GlobeNewswire · 22d ago
Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers
GlobeNewswire · 29d ago
How Investors Are Reacting To Merit Medical Systems (MMSI) New Global Operations Leadership Transition
Simply Wall St. · 35d ago
SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth
GlobeNewswire · 42d ago
Merit Medical Announces Global Operations Leadership Transition
GlobeNewswire · 48d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.